In vitro studies on the sensitivity pattern of Plasmodium falciparum to anti-malarial drugs and local herbal extracts

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Olasehinde, Grace I ^a   Ojurongbe, Olusola ^b   Adeyeba, Adegboyega O ^b   Fagade, Obasola E ^c   Valecha, Neena ^d   Ayanda, Isaac O ^a   Ajayi, Adesola A ^a   Egwari, Louis O ^a  

^a Department of Biological Sciences Covenant University ^*  (Nigeria)

^b LAUTECH TEACHING HOSPITAL   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

Anti malarial; In vitro; Isolates; Local herbs; Sensitivity

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE; DIOSPYROS MONBUTTENSIS EXTRACT; MEFLOQUINE; MOMORDICA CHARANTIA EXTRACT; MORINDA LUCIDA EXTRACT; PLANT EXTRACT; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; UNCLASSIFIED DRUG;

ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; BACTERIUM ISOLATE; CORRELATION ANALYSIS; CRYOPRESERVATION; DIOSPYROS MONBUTTENSIS; DRUG ACTIVITY; FEMALE; HERBAL MEDICINE; HUMAN; IC 50; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; MOMORDICA CHARANTIA; MORINDA LUCIDA; NONHUMAN; PARASITE CULTIVATION; PLANT LEAF; PLASMODIUM FALCIPARUM; SCHIZONT; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; ANTIMALARIALS; DIOSPYROS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MOMORDICA CHARANTIA; MORINDA; NIGERIA; PLANT EXTRACTS; PLASMODIUM FALCIPARUM; YOUNG ADULT;

EID: 84899489787     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-63     Document Type: Article

References (39)

1. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. McCollum AM, Poe AC, Hamel M, Huber C, Zhou Z, Shi PY, Ouma P, Vulule J, Bloland P, Slutsker L, Barnwell JW, Udhayakumar V, Escalante AA, J Infect Dis 2006 194 189 197 10.1086/504687 16779725
2. Bloland BP, Drug resistance in malaria Geneva: World Health Organization 2001 WHO/CDS/CSR/DRS/2001.4:1
3. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Eng J Med 2008 359 2619 2620 10.1056/NEJMc0805011
4. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F, Lancet 2012 379 1960 1966 10.1016/S0140-6736(12)60484-X 22484134
5. Chloroquine resistance in the malarial parasite, Plasmodium falciparum. Ursos LM, Roepe PD, Med Res Rev 2002 22 465 491 10.1002/med.10016 12210555
6. Chloroquine resistant Plasmodium falciparum in Thailand: susceptibility of Anopheles. Sucharit S, Surathin K, Tumrasvin W, Sucharit P, J Med Ass Thai 1977 60 648 654
7. Antimalarial activities of some selected traditional herbs from Southeastern Nigeria against Plasmodium species. Ogbonna DN, Sokari TG, Agomuoh AA, Res J Parasitol 2008 3 25 31
8. Medicinal plants: a re-emerging health aid. Hoareau L, Dasilva EJ, Elec J Biotech 1999 2 56 69
9. Ethnopharmacology and malaria: New hypothetical leads or old efficient antimalarials? Bourdy M, Willcox L, Ginsburg H, Rasoanaivo P, Graz B, Deharo E, Intl J Parasitol 2008 38 33 41 10.1016/j.ijpara.2007.07.004
10. Evaluation of the antimalarial activity of Morinda lucida using both in vivo and in vitro techniques. Awe SO, Makinde JM, W Afr J Pharma Drugs Res 1997 13 39 44
11. Synergistic in vitro antimalarial activity of plant extracts used as traditional herbal remedies in Mali. Azas N, Laurencin N, Delmas F, Di-Giorgio C, Gasquet M, Laget M, Timon-David P, Parasitol Res 2002 88 165 171 10.1007/s004360100454 11936507
12. Anti-inflammatory and analgesic activities of Cassia goratensis and Sacrocephalus esculentus extracts. Otimenyin SO, Uguru MO, Auta A, Journal of Herbs, Spices & Medicinal Plants 2008 13 59 67 10.1300/J044v13n02-05
13. The co-evolution of people, plants, and parasites: biological and cultural adaptations to malaria. Etkin NL, Proc Nut Soc 2003 62 311 317 10.1079/pns2003244
14. Biologically active substances from the genus Artemisia. Tan RX, Zheng WF, Tang HQ, Planta Med 1998 64 295 302 10.1055/s-2006-957438 9619108
15. Traditional medical development for medical and dental primary healthcare delivery system in Africa. Elujoba AA, Odeleye OM, Ogunyemi CM, Afr J Tradit Complem 2005 2 46 61
16. Willcox M, Bodeker G, Rasoanaivo P, Traditional Medicinal Plants and Malaria UK: CRC Press 2004
17. In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa. Clarkson C, Maharaj VJ, Crouch NR, Grace OM, Pillay P, Matsabisa MG, J Ethnopharmacol 2004 92 177 191 10.1016/j.jep.2004.02.011 15137999
18. Some medicinal plants used in Yemeni herbal medicine to treat malaria. Ali AN, Al-rahwi AK, Lindequist U, Afr J Tradit Complem 2004 1 72 76
19. Selective antiprotozoal activity of some Strychnos alkaloids. Wright CW, Allen D, Cai Y, Chen ZP, Phillipson JD, Kirby GC, Warhurst DC, Tits M, Angenot L, Phytother Res 1994 8 149 152 10.1002/ptr.2650080306
20. Evaluation in vitro and in vivo of a traditional antimalarial drug, 'malarial 5'. Gasquet M, Delmas F, Timon-David P, Keita A, Guindo M, Koita N, Diallo D, Doumbo O, Fitoterapia 1993 64 423 426
21. The role of pharmacognosy in phytotherapy, the challenges of our time. Elujoba AA, Nigerian Journal of Natural Products and Medicine 1998 2 5 8
22. WHO, Expert Committee on Malaria, 20th Report Geneva: World Health Organization Technical Report Series 2000 892
23. Cheesbrough M, District laboratory practice manual in Tropical Countries pt 2 UK: Cambridge University Press 2000 434
24. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. WHO, Bull World Health Org 1990 68 53 59 2189586
25. Colorimetric in vitro drug sensitivity assay for P. falciparum based on a highly sensitive double- site pLDH antigen capture ELISA assay. Druilhe P, Moreno A, Blanc C, Brasseur P, Jacquier P, Am J Trop Med Hyg 2001 64 233 241 11463109
26. Long-term cultivation of Plasmodium falciparum in media with commercial non-serum supplements. Flores MVC, Berger-Eiszele SM, Stuart TS, Parasitol Res 1997 83 734 736 10.1007/s004360050330 9272569
27. Noedl H, Non linear evaluation of malaria drug sensitivity data (HN-NonLin V1.1) Bangkok, Thailand: Armed Forces Research Institute for Medical Sciences 2002 http://www.meduniwien.ac.at/user/harald.noedl/malaria/download. html
28. WHO, In vitro micro-test (Mark III) for the assessment of P. falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine/pyrimethamine and artemisinin Geneva, Switzerland: CTD/MAL/9720 Rev 2 2001
29. Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. Happi CT, Gbotosho GO, Sowunmi A, Falade CO, Akinboye DO, Hudson T, Gerena L, Kyle DE, Milhous W, Wirth DF, Oduola AMJ, Am J Trop Med Hyg 2004 70 20 26 14971693
30. Comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in Northcentral Nigeria. Ogunfowokan O, Dankyau M, Madaki AJ, Thacher TD, Am J Trop Med Hyg 2009 80 199 201 19190213
31. Field-based evidence for the linkage of pfcrt and pfdhfr drug-resistant malaria genotypes and clinical profiles for severe malaria in Niger. Ibrahim ML, Gay-Andrieu F, Adehossi E, Lacroix V, Randrianarivelojosia M, Duchemin JB, Microbes Infect 2007 9 599 604 10.1016/j.micinf.2007.02.003 17409009
32. Pharmacovigilance of antimalarial treatment in Africa: is it possible? Talisuna AO, Staedke SG, D'Alessandro U, Malar J 2006 5 50 10.1186/1475-2875-5- 50 16780575
33. In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine. Pradines M, Mabika M, Parzy D, Owono MM, Lebeau C, Mourou MJR, Doury JC, Kombila M, Am J Trop Med Hyg 1999 60 105 108 9988332
34. Drug sensitivity of Plasmodium falciparum in Gabon: activity correlations between various antimalarials. Winkler S, Brandts C, Wernsdorfer WH, Graninger W, Bienzle U, Kremsner PG, Trop Med Parasitol 1994 45 214 218 7899790
35. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria. Ashley AA, Stepniewska K, Lindegårdh N, McGready R, Hutagalung R, Singtoroj T, Hla G, Brockman A, Proux S, Wilahphaingern J, Singhasivanon P, White NJ, Nosten F, Trop Med Int Health 2007 12 201 208 10.1111/j.1365-3156.2006.01785.x 17300626
36. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Sodiomon BS, Alfred BT, Adama G, Amidou D, Amidou O, Amadou TK, Jean-Rene K, Morgan CC, Olliaro PL, Walter RJT, Malar J 2009 8 48 10.1186/1475-2875-8-48 19291301
37. WHO, Monitoring antimalarial drug resistance: a report of a consultation Geneva, Switzerland: WHO/CDS/CSR/EPH/2002.17. WHO/CDS/RBM/2002.39 2003
38. Assessment of antimalarial activity against Plasmodium falciparum and phytochemical screening of some Yemeni medicinal plants. Alshawsh MA, Mothana RA, Al-Shamahy HA, Alsllami SF, Lindequist U, Evid Based Complement Alternat Med 2009 6 453 456 10.1093/ecam/nem148 10.1093/ecam/nem148 18955251
39. Antifungal anthaquinones from Morinda lucida. Guido R, Menavanza N, Kurt H, Int J Pharmacol 1995 33 107 114 10.3109/13880209509055208